On October 1, 2023, it was reported that Citigroup had lowered its target price for Nu Skin Enterprises (NYSE:NUS) from $30.00 to $23.00. This adjustment was noted in a report released by FlyOnTheWall. With this revised target price, Citigroup suggests a potential upside of 6.78% from the current price of the company.
As of Friday, NYSE:NUS shares opened at $21.54. The company’s stock has been experiencing fluctuations, with a 50-day moving average of $24.91 and a 200-day moving average of $32.31. Nu Skin Enterprises has seen a range of prices over the past year as well, with lows of $20.98 and highs of $45.55.
Looking at some key financial figures, Nu Skin Enterprises currently boasts a market capitalization of $1.08 billion and operates with a price-to-earnings ratio of 15.28 and a beta value of 1.19. Additionally, the company holds a debt-to-equity ratio of 0.41.
In terms of liquidity ratios, Nu Skin Enterprises has a current ratio of 1.78 and a quick ratio of 0.94.
Taking into account changes made by institutional investors in their positions regarding the stock, it is evident that Eagle Bay Advisors LLC increased its holdings in Nu Skin Enterprises by 37.1% during the second quarter, acquiring an additional 219 shares valued at $35,000 overall.
Price T Rowe Associates Inc., MD also raised its position in the company during the same period by 1.% to own an additional 292 shares amounting to $875,000.
Raymond James & Associates increased its stake by 3.% in the first quarter where it now owns approximately 9,829 shares worth $386,000
Captrust Financial Advisors also saw an increase in its holdings, raising it by 12.7% during the second quarter and acquiring an additional 413 shares valued at $158,000.
Lastly, SummerHaven Investment Management LLC now possesses approximately 18,772 shares of Nu Skin Enterprises’ stock after boosting its stake by 2.3% in the first quarter, translating to a value of $738,000.
In terms of recent financial performance, Nu Skin Enterprises released its quarterly earnings data on August 1st. The company reported earnings per share (EPS) of $0.54 for the quarter, surpassing analysts’ consensus estimates by $0.01. However, revenue figures fell short compared to estimates with $500.26 million generated during the quarter instead of the anticipated $512.35 million.
Despite these results, the company showcased a return on equity of 12.88% and achieved a net margin of 3.43%.
Sell-side analysts forecast an expectation that Nu Skin Enterprises will post earnings per share (EPS) of 2.47 for the current year.
As investors monitor Citigroup’s revised target price and take into account recent financial performance figures and institutional investors’ activities surrounding Nu Skin Enterprises’ stock, time will reveal how these dynamics impact the company’s trajectory moving forward.
[bs_slider_forecast ticker=”CDNS”]
Insider Selling Casts Doubt on Nu Skin Enterprises’ Stock
On October 1, 2023, Nu Skin Enterprises saw several brokerages comment on its stock and provide ratings and target prices. DA Davidson reduced their target price on Nu Skin Enterprises shares from $38.00 to $29.00, assigning a “neutral” rating. Similarly, StockNews.com initiated coverage on Nu Skin Enterprises, giving it a “hold” rating. Stifel Nicolaus also decreased the company’s price objective from $43.00 to $35.00 and rated it as “hold.” Overall, five equities research analysts have given the stock a hold rating.
The general consensus from these analysts is that there is no overwhelming bullish sentiment towards Nu Skin Enterprises at present. The average rating for the stock is reported as “Hold,” with an average target price of $31.50 according to data from Bloomberg.
In other news related to Nu Skin Enterprises, Director Andrew D. Lipman sold 2,000 shares of the company’s stock on Tuesday, July 25th. These shares were sold at an average price of $28.99 each, resulting in a total transaction value of $57,980.00. Following this sale, Lipman now holds 58,625 shares of Nu Skin Enterprises’ stock with an approximate value of $1,699,538.75.
Another director involved in selling the company’s stock was Emma S. Battle who sold 1,272 shares on Monday, August 7th at an average price of $26.15 per share for a total transaction worth $33,262.80. After this transaction, Battle now owns 7,619 shares valued at approximately $199,236.85.
It should be noted that Andrew D. Lipman made another sale involving 2,000 shares on Tuesday, July 25th at an average price of $28.99 per share for a total transaction value of $57,980.00. Post-transaction, Lipman’s ownership stands at 58,625 shares with an estimated value of $1,699,538.75.
These transactions were disclosed in legal filings with the SEC and can be accessed using the provided hyperlink.
Additionally, it is worth mentioning that insiders have collectively sold 13,340 shares of Nu Skin Enterprises’ stock in the last quarter alone. The total value of these sales amounts to $330,303. Insiders currently hold a 2.00% stake in the company.
Overall, this recent activity involving insider selling raises questions about the sentiment surrounding Nu Skin Enterprises’ stock. With several brokerages rating it as “neutral” or “hold,” and notable director sell-offs occurring recently, investors may want to exercise caution when considering investing in this particular company at its current valuation.
